What is the price-to-earnings ratio of Xencor?
The price-earnings ratio of Xencor is currently 20.89.
Xencor P/S 2024
Xencor P/S
20.89
Ticker
XNCR
ISIN
US98401F1057
WKN
A1W96L
As of Aug 25, 2024, Xencor's P/S ratio stood at 20.89, a 114.26% change from the 9.75 P/S ratio recorded in the previous year.
The Xencor P/S history
Xencor Aktienanalyse
What does Xencor do?
The company Xencor Inc was founded in 1997 and has since become a significant biotechnology company specializing in the development of therapeutic proteins. Xencor's goal is to develop innovative and tailored therapies for the treatment of serious diseases such as cancer and autoimmune diseases. The company is headquartered in Monrovia, California, and employs a growing number of scientists, engineers, and other professionals specialized in the development of new themes and products. Xencor has acquired a variety of patents over the years to protect its intellectual property. Its business model is based on the development of new therapeutics through its proprietary XmAb technology platform, which enables the production of highly specific polyclonal antibodies that can improve the efficiency and safety of disease treatments. Xencor has divided its business activities into various divisions, including the development of immuno-oncology products, autoimmune therapies, and new methods for the therapy of inflammatory bowel diseases. The company has developed a wide range of products, including a new class of therapeutic antibodies that mobilize and strengthen patients' own immune system to fight cancer cells. By combining these antibodies with other therapies, the effectiveness of the treatment can be further increased. In the autoimmune diseases division, Xencor has developed new therapeutics to better regulate patients' immune system and treat dangerous autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, or lupus. Another focus of the company is the development of therapies for inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. By developing specific antibodies involved in the inflammatory processes in the intestine, Xencor can contribute to improving the treatment of these conditions. Xencor aims to accelerate the development of new therapeutics while improving their efficacy and safety. With the help of its proprietary XmAb technology platform, the company is able to develop new drugs faster and more effectively than conventional methods. Through the combination of technology, research and development, and a high level of commitment, Xencor pursues its vision and has successfully established itself as one of the leading companies in the biotechnology industry. Xencor ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Xencor's P/S Ratio
Xencor's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Xencor's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Xencor's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Xencor’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Xencor stock
How has the price-earnings ratio of Xencor changed compared to last year?
The price-to-earnings ratio of Xencor has increased by 114.26% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Xencor high compared to other companies?
Yes, the price-to-earnings ratio of Xencor is high compared to other companies.
How does an increase in the price-earnings ratio of Xencor affect the company?
An increase in the price-earnings ratio of Xencor would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Xencor affect the company?
A decrease in the price-earnings ratio of Xencor would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Xencor?
Some factors that influence the price-earnings ratio of Xencor are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Xencor pay?
Over the past 12 months, Xencor paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xencor is expected to pay a dividend of 0 USD.
What is the dividend yield of Xencor?
The current dividend yield of Xencor is .
When does Xencor pay dividends?
Xencor pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Xencor?
Xencor paid dividends every year for the past 0 years.
What is the dividend of Xencor?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Xencor located?
Xencor is assigned to the 'Health' sector.
Wann musste ich die Aktien von Xencor kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Xencor from 8/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/25/2024.
When did Xencor pay the last dividend?
The last dividend was paid out on 8/25/2024.
What was the dividend of Xencor in the year 2023?
In the year 2023, Xencor distributed 0 USD as dividends.
In which currency does Xencor pay out the dividend?
The dividends of Xencor are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Xencor stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Xencor
Our stock analysis for Xencor Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xencor Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
